Peter M. Anderson MD PhD
Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Staff Physician
Join to View Full Profile
9500 Euclid AveCleveland Clinic Pediatric Heme/Onc/BMT R3Cleveland, OH 44195
Phone+1 216-308-2706
Fax+1 216-444-3577
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Peter Anderson is a Pediatric Oncologist based in Cleveland, OH, specializing in Pediatric Hematology & Oncology with subspecialties in Pediatric Sarcoma Oncology and Pediatric Solid Tumor Oncology. He completed his Pediatrics and Internal Medicine residencies at Duke University Hospital and a fellowship in Pediatric Hematology/Oncology at the University of Minnesota. Since 2015, he has been employed at the Cleveland Clinic and has extensive experience in pediatric sarcomas and solid tumors. Dr. Anderson has contributed to numerous peer-reviewed publications, particularly in the areas of pediatric oncology and novel therapeutic trials. He has been involved in multiple clinical trials focusing on treatments for Ewing's Sarcoma and other pediatric cancers. His professional honors include faculty positions at eminent institutions and recognition as a top doctor.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1985 - 1988
Duke University HospitalResidency, Pediatrics, 1983 - 1985- Duke University HospitalResidency, Internal Medicine, 1981 - 1983
Icahn School of Medicine at Mount SinaiClass of 1981
Certifications & Licensure
CA State Medical License 2024 - 2028
MI State Medical License 2025 - 2028
IN State Medical License 2025 - 2027
OH State Medical License 2015 - 2027
NV State Medical License 2024 - 2027
NJ State Medical License 2025 - 2027
MT State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Awards, Honors, & Recognition
- Professor Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
- Professor University of Texas MD Anderson CancerCenter, 2005
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma Start of enrollment: 2008 Jan 01
- Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy Start of enrollment: 2008 May 01
- TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Publications & Presentations
PubMed
- Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis.Jenna Kocsis, Shauna R Campbell, Jonathan Jang, Eashwar Somasundaram, Chandana A Reddy
Pediatric Blood & Cancer. 2026-03-01 - Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure.Andrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, Yifeng Ma, Shinjini Ganguly
Pediatric Blood & Cancer. 2025-09-01 - 17 citationsOpen-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis
Journal of Clinical Oncology. 2024-11-01
Press Mentions
- 'Always Keep Your Hope': Cleveland Heights Woman Names Son After Oncologist Who Helped Save Her LifeMay 25th, 2022
Len Rome’s Local Health: Childhood Cancer Patient Finds Hope and Treatment in Northeast OhioOctober 1st, 2020
Young Girl Is Cancer-Free After Yearlong Battle with Rare SarcomaSeptember 24th, 2020
Grant Support
- 153 Sm-Edtmp For Bone Metastases--Phase I Dose Escalation StudyNational Center For Research Resources1998–2002
- IL-2 Liposomes In Cancer Of The LungNational Cancer Institute1991–1995
Professional Memberships
- Member
- ASPHOMember
- SIOPMember
- Member
- CTOSMember
Industry Relationships
- Inventor, Healiosglutamine+ disaccharide (trehalose) to reduce mucositis (stomatitis, esophagitis, enteritis)Disclosure: Enlivity Scientific Advisory Board2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
